Cargando…
Vaccine‐induced immune thrombotic thrombocytopenia (VITT) – a novel clinico‐pathological entity with heterogeneous clinical presentations
Vaccine‐induced immune thrombotic thrombocytopenia (VITT) is a novel entity that emerged in March 2021 following reports of unusual thrombosis after ChAdOx1 nCoV‐19, (AstraZeneca) vaccination. Following the recognition of this syndrome, multiple consensus guidelines have been released to risk strati...
Autores principales: | Lavin, Michelle, Elder, Patrick T., O’Keeffe, Denis, Enright, Helen, Ryan, Eileen, Kelly, Anna, El Hassadi, Ezzat, McNicholl, Feargal P., Benson, Gary, Le, Giao N., Byrne, Mary, Ryan, Kevin, O’Connell, Niamh M., O’Donnell, James S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444927/ https://www.ncbi.nlm.nih.gov/pubmed/34159588 http://dx.doi.org/10.1111/bjh.17613 |
Ejemplares similares
-
Vaccine-induced thrombosis and thrombocytopenia (VITT) in Ireland: A review of cases and current practices
por: Swan, D., et al.
Publicado: (2021) -
Vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Warkentin, Theodore E.
Publicado: (2022) -
Understanding vaccine‐induced thrombotic thrombocytopenia (VITT)
por: Dix, Caroline, et al.
Publicado: (2022) -
Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Greinacher, Andreas, et al.
Publicado: (2022) -
Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Gabarin, Nadia, et al.
Publicado: (2022)